Massimo Donadelli

19PUBLICATIONS

55CO-AUTHORS

Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Medical mycologyHaematological tumours

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (19)

Sort by Publication Date:

|May 26, 2026

First-in-Class Covalent Inhibitors of PFKFB3: Discovery and Characterization in PDAC Models.

|Oct 28, 2025

Chemotherapy enhances HMGA1 secretion through the mutant p53-CK2 axis in pancreatic ductal adenocarcinoma cells.

Federica Danzi, Giovanna Butera, Damien Sutton

|Aug 17, 2025

Mutant p53 affects the mitochondrial proteome, promoting mitochondrial fragmentation and OXPHOS in pancreatic ductal adenocarcinoma cells.

Maria Poles, Raffaella Pacchiana, Chiara Mortali

|May 13, 2025

Correction: Belisario et al. ABCA1/ABCB1 Ratio Determines Chemo- and Immune-Sensitivity in Human Osteosarcoma. <i>Cells</i> 2020, <i>9</i>, 647.

Dimas Carolina Belisario, Muhlis Akman, Martina Godel

|Oct 25, 2024

Microgravity as a Tool to Investigate Cancer Induction in Pleura Mesothelial Cells.

Valentina Bonetto, Corinna Anais Pagano, Maurizio Sabbatini

|Feb 10, 2024

CD99 Modulates the Proteomic Landscape of Ewing Sarcoma Cells and Related Extracellular Vesicles.

Alessandra De Feo, Marcello Manfredi, Caterina Mancarella

Pageof 4

Frequent Collaborators

4 joint publications

Chiara Riganti

3 joint publications

Marco Cordani

2 joint publications

Miguel Sánchez-Álvarez

Alexandr V Bazhin

Giuseppe De Rosa

Massimo Serra

Aldo Scarpa

Joanna Kopecka

Elisa Dalla Pozza

Ilaria Dando

Frequent Collaborators

4 joint publications

Chiara Riganti

3 joint publications

Marco Cordani

2 joint publications

Miguel Sánchez-Álvarez

2 joint publications

Alexandr V Bazhin